Desloratadina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Desloratadina" in Italian language version.

refsWebsite

Global rank Italian rank

16nih.gov

4^th place

9^th place

6doi.org

2^nd place

7^th place

4oadoi.org

799^th place

22^nd place

2web.archive.org

1^st place

1fda.gov

447^th place

644^th place

1bmjjournals.com

low place

bmjjournals.com

bmj.bmjjournals.com

Mann R, Pearce G, Dunn N, Shakir S, Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice, in BMJ, vol. 320, n. 7243, 2000, pp. 1184–6, DOI:10.1136/bmj.320.7243.1184, PMC 27362, PMID 10784544.

doi.org

dx.doi.org

RS. Geha, EO. Meltzer, Desloratadine: A new, nonsedating, oral antihistamine., in J Allergy Clin Immunol, vol. 107, n. 4, Apr 2001, pp. 751-62, DOI:10.1067/mai.2001.114239, PMID 11295678.
Mann R, Pearce G, Dunn N, Shakir S, Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice, in BMJ, vol. 320, n. 7243, 2000, pp. 1184–6, DOI:10.1136/bmj.320.7243.1184, PMC 27362, PMID 10784544.
JB. Hong, HC. Lee; FC. Hu; CY. Chu, A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 63, n. 5, Nov 2010, pp. e100-2, DOI:10.1016/j.jaad.2010.03.007, PMID 20950731.
C. Bachert, M. Maurer, Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies., in Clin Drug Investig, vol. 30, n. 2, 2010, pp. 109-22, DOI:10.2165/11530930-000000000-00000, PMID 20067329.
M. Augustin, S. Ehrle, Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients., in J Eur Acad Dermatol Venereol, vol. 23, n. 3, Mar 2009, pp. 292-9, DOI:10.1111/j.1468-3083.2008.03034.x, PMID 19438819.
Glass D, Harper A, Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine, in BMC Fam Pract, vol. 4, 13 agosto 2003, p. 10, DOI:10.1186/1471-2296-4-10, PMC 194638, PMID 12917016 (archiviato dall'url originale l'8 maggio 2006).

fda.gov

FDA Electronic Orange Book http://www.fda.gov/cder/ob/default.htm

nih.gov

ncbi.nlm.nih.gov

RS. Geha, EO. Meltzer, Desloratadine: A new, nonsedating, oral antihistamine., in J Allergy Clin Immunol, vol. 107, n. 4, Apr 2001, pp. 751-62, DOI:10.1067/mai.2001.114239, PMID 11295678.
SP. Clissold, EM. Sorkin; KL. Goa, Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy., in Drugs, vol. 37, n. 1, Jan 1989, pp. 42-57, PMID 2523301.
Mann R, Pearce G, Dunn N, Shakir S, Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice, in BMJ, vol. 320, n. 7243, 2000, pp. 1184–6, DOI:10.1136/bmj.320.7243.1184, PMC 27362, PMID 10784544.
M. Affrime, S. Gupta; C. Banfield; A. Cohen, A pharmacokinetic profile of desloratadine in healthy adults, including elderly., in Clin Pharmacokinet, 41 Suppl 1, 2002, pp. 13-9, PMID 12169042.
K. McClellan, B. Jarvis, Desloratadine., in Drugs, vol. 61, n. 6, 2001, pp. 789-96; discussion 797, PMID 11398910.
EJ. Wang, CN. Casciano; RP. Clement; WW. Johnson, Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein., in Drug Metab Dispos, vol. 29, n. 8, Aug 2001, pp. 1080-3, PMID 11454724.
AS. Nayak, E. Schenkel, Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis., in Allergy, vol. 56, n. 11, Nov 2001, pp. 1077-80, PMID 11703222.
CE. Baena-Cagnani, Desloratadine activity in concurrent seasonal allergic rhinitis and asthma., in Allergy, 56 Suppl 65, 2001, pp. 21-7, PMID 11243501.
C. Bachert, Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis., in Allergy, 56 Suppl 65, 2001, pp. 14-20, PMID 11243500.
H. Farkas, [Multicenter study of the effectiveness and tolerability of desloratadine in seasonal allergic rhinitis]., in Orv Hetil, vol. 144, n. 21, maggio 2003, pp. 1021-4, PMID 12847854.
JB. Hong, HC. Lee; FC. Hu; CY. Chu, A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 63, n. 5, Nov 2010, pp. e100-2, DOI:10.1016/j.jaad.2010.03.007, PMID 20950731.
C. Bachert, M. Maurer, Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies., in Clin Drug Investig, vol. 30, n. 2, 2010, pp. 109-22, DOI:10.2165/11530930-000000000-00000, PMID 20067329.
M. Augustin, S. Ehrle, Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients., in J Eur Acad Dermatol Venereol, vol. 23, n. 3, Mar 2009, pp. 292-9, DOI:10.1111/j.1468-3083.2008.03034.x, PMID 19438819.
Glass D, Harper A, Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine, in BMC Fam Pract, vol. 4, 13 agosto 2003, p. 10, DOI:10.1186/1471-2296-4-10, PMC 194638, PMID 12917016 (archiviato dall'url originale l'8 maggio 2006).
See S, Desloratadine for allergic rhinitis, in Am Fam Physician, vol. 68, n. 10, 2003, pp. 2015–6, PMID 14655812. URL consultato il 12 febbraio 2011 (archiviato dall'url originale il 24 luglio 2005).
D. Glass, A. Harper, Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine., in Manag Care Interface, vol. 17, n. 2, Feb 2004, pp. 29-34, PMID 15038691.

oadoi.org

RS. Geha, EO. Meltzer, Desloratadine: A new, nonsedating, oral antihistamine., in J Allergy Clin Immunol, vol. 107, n. 4, Apr 2001, pp. 751-62, DOI:10.1067/mai.2001.114239, PMID 11295678.
JB. Hong, HC. Lee; FC. Hu; CY. Chu, A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 63, n. 5, Nov 2010, pp. e100-2, DOI:10.1016/j.jaad.2010.03.007, PMID 20950731.
C. Bachert, M. Maurer, Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies., in Clin Drug Investig, vol. 30, n. 2, 2010, pp. 109-22, DOI:10.2165/11530930-000000000-00000, PMID 20067329.
M. Augustin, S. Ehrle, Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients., in J Eur Acad Dermatol Venereol, vol. 23, n. 3, Mar 2009, pp. 292-9, DOI:10.1111/j.1468-3083.2008.03034.x, PMID 19438819.

web.archive.org

Glass D, Harper A, Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine, in BMC Fam Pract, vol. 4, 13 agosto 2003, p. 10, DOI:10.1186/1471-2296-4-10, PMC 194638, PMID 12917016 (archiviato dall'url originale l'8 maggio 2006).
See S, Desloratadine for allergic rhinitis, in Am Fam Physician, vol. 68, n. 10, 2003, pp. 2015–6, PMID 14655812. URL consultato il 12 febbraio 2011 (archiviato dall'url originale il 24 luglio 2005).